Using video calls to reduce stress in parents of NICU infants
Impact of Serial Bedside Video Call Communication on Stress Level in Parents of Infants Admitted to NICU.
This study is testing if regular video calls can help lower stress for parents of babies in the NICU who have been there for over a week.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 7 Days to 60 Days |
| Sex | All |
| Sponsor | Cook County Health Government |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06252883 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to assess whether serial bedside video calls with audio can lower stress levels in parents of infants admitted to the NICU for over seven days. Parents will be randomly assigned to either receive video calls 2-3 times a week in addition to routine updates or only the standard updates. The study will evaluate the impact of these video interactions on parental anxiety and stress through questionnaires administered at three points over an eight-week period. This approach seeks to enhance the parent-infant relationship during a challenging time.
Who should consider this trial
Good fit: Ideal candidates for this study are parents of newborns who have been in the NICU for at least seven days.
Not a fit: Parents of infants with significant medical conditions such as major congenital anomalies or drug exposure may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce parental stress and anxiety, improving the overall well-being of families with infants in the NICU.
How similar studies have performed: While studies have explored parental stress in the NICU, this specific approach using video calls is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Newborns with 7 days or more of NICU stay Exclusion Criteria: Infant with * intrauterine drug exposure * major critical congenital cardiac anomaly * major neurologic anomaly * chromosomal disorder.
Where this trial is running
Chicago, Illinois
- John H. Stroger Hospital of Cook County — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Nanda Vishakha, MD — John H Stroger Hospital of Cook County, IL
- Study coordinator: Nanda Vishakha, MD
- Email: vishakha.nanda@cookcountyhhs.org
- Phone: 312-864-6000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.